CLOs on the Move

STS Life Sciences Division, Ethox International

www.stsduotek.com

 
STS Life Sciences Division, Ethox International is a Rush, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

LivaNova

At LivaNova we strive to help where it really counts, where it truly matters the most. Where every single effort, of each one of us, is transformational and expected to leave a lasting mark. That is why at LivaNova we make each innovation count: global, accessible, relevant and breakthrough. Transforming medical innovation into meaningful solutions, into a sustainable healthcare system and ultimately into healthier and – importantly - better lives.

Miltex

For more than 50 years, Miltex, Inc. has established itself as the largest and most respected supplier of hand-held surgical instruments in the alternate site market. Unique among its competitors, Miltex, Inc., through Miltex GmbH in Rietheim-Weiltheim,

Curbell Electronics

Curbell Electronics is a Orchard Park, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

brookdale medical

brookdale medical is a Woodbridge, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Seno Medical Instruments

Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging. Seno`s Imagio breast imaging system fuses opto-acoustic technology with ultrasound to generate functional and anatomical images of the breast. The opto-acoustic images provide a unique blood map in and around suspicious breast masses while the ultrasound provides a traditional anatomic image. Through the appearance or absence of the two hallmark indicators of cancer – angiogenesis and deoxygenation – Seno believes that the Imagio OA breast imaging system will be a more effective tool to help radiologists confirm or rule out malignancy than current diagnostic imaging modalities – without exposing patients to potentially harmful ionizing radiation (x-rays) or contrast agents.